A recent study suggests that patients who come off popular slimming jabs like Mounjaro or Wegovy tend to recover lost weight much more quickly than those who end traditional lifestyle regimens.
Published data in a major health publication points out that while obese individuals frequently drop a large proportion of their total mass while using the jabs, the mass is regained at an average rate of 0.8 kg per month after stopping.
"Individuals using these treatments should be cognizant of the danger of fast weight regain when the therapy is stopped," cautioned expert Dr. Susan Jebb.
That rate of recovery suggests a reversion to pre-treatment mass in about one and a half years.
Analyzing Approaches
The analysis, which looked at dozens of trials involving over 9,000 of patients, contrasted the effects of these new drugs with older methods.
Researchers note that people who shed pounds through dieting generally experience a less rapid weight regain—approximately 100 grams monthly—after stopping.
Explaining the Quick Rebound
Experts believe the mechanism of the jabs explains the amplified rebound.
The injections imitate a body's own chemical called GLP-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations several times higher than normal may cause the system to generate a reduced amount of its own natural GLP-1, and could lessen responsiveness to its effects," said Dr. Adam Collins, a nutrition specialist.
"Stopping of this medication leads to hunger is uncontrolled, making overeating far more likely."
A Chronic Disease?
The NHS recommend the jabs for people with obesity-related health risks, accompanied by prescribed lifestyle changes.
A number of clinicians say that, given the significant potential of relapse, the treatment might need to be long-term.
This view is supported by pharmaceutical companies, who note that the findings "emphasize the persistent character of obesity," similar to managing diseases like high blood pressure.
Patient Testimonies
People who have come off the jabs report a intense return of cravings.
"It felt as if a switch flipping and you become ravenous," recalled a patient.
This difficulty is worsened if individuals have not adopted lasting lifestyle or habit modifications during therapy.
Significant Adoption
Survey data indicate that a significant number of people in the UK have used these injections in the last 12 months, with interest being substantial.
- Use is greater among women compared to males.
- The 40s and 50s age group shows the highest level of interest.
- Many obtain the medications through private healthcare rather than public health services.
In conclusion, experts stress that while the jabs are effective agents for weight loss, they are not a permanent solution and maintained weight loss likely depends on combined behavioural changes.
